Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Latest filing published 09 Sept 2026 for Barinthus Biotherapeutics plc.. Read the official filing
Filing timeline
BuySaleKaren A. Dawes
Insider track record
Disclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Karen A. Dawes: trading record in brief
Karen A. Dawes (senior executive) discloses dealings in 2 companies, chiefly Repligen Corp and Vaccitech plc. The record holds 22 filings, for trades running from 4 May 2021 to 9 September 2026.
Both buying and selling appear: 1 purchase worth €24k, against 7 sales worth €840k. Netting one side against the other leaves €816k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants and 8 option exercises.
The newest entry dates from 9 September 2026: a transaction, in Vaccitech plc. The last insider purchase was made public on 6 May 2021, 1,991 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Karen A. Dawes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,700 sharesOrdinary SharesSEC:0001104659-26-106323:0
275 shares@ US$161.003.3% of flowCommon StockSEC:0001193125-25-324912:0
973 shares0Common StockSEC:0000950170-25-074251:0
2,953 shares@ US$67.7113.7% of flowCommon StockSEC:0000950170-24-073829:0
803 shares0Common StockSEC:0000950170-24-062599:0
4,626 shares@ US$42.0713.2% of flowCommon StockSEC:0000950170-24-022581:0
7,392 shares@ US$18.129.1% of flowCommon StockSEC:0000950170-23-045417:0
798 shares0Common StockSEC:0000899243-23-013671:0
775 shares@ US$227.1713.0% of flowCommon StockSEC:0000899243-22-030728:0
644 shares0Common StockSEC:0000899243-22-020280:0
2,576 shares@ US$149.1835.0% of flowCommon StockSEC:0000899243-22-019772:0
4,783 shares@ US$26.1210.5% of flowCommon StockSEC:0000899243-21-044418:0
64 shares@ US$299.021.6% of flowCommon StockSEC:0000899243-21-043038:0
13 shares@ US$290.020.3% of flowCommon StockSEC:0000899243-21-036134:0
3,459 shares@ US$38.7611.0% of flowCommon StockSEC:0000899243-21-034897:0
924 shares@ US$251.1519.3% of flowCommon StockSEC:0000899243-21-033643:0
2,929 shares@ US$41.190.0013% mcap9.1% of flowCommon StockSEC:0000899243-21-029533:0
288 shares@ US$200.014.8% of flowCommon StockSEC:0000899243-21-029561:0
2,929 shares@ US$41.1910.0% of flowCommon StockSEC:0000899243-21-028505:0
604 shares0Common StockSEC:0000899243-21-019705:0
15,000 shares@ US$3.223.5% of flowCommon StockSEC:0000899243-21-019419:0
1,700 shares@ US$17.00100.0% of flowOrdinary SharesSEC:0001104659-21-062434:0
Canonical exit: 2 Aug 2021 (T+90)
22 of 22 declarations
